Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related mortality. Although the underlying ...

31 in the Journal of Translational Medicine. Dan-Dan Zhang, from Qingdao Municipal Hospital at Qingdao University in China, ...

Collaborative research is driving the development of future treatments to ease symptoms of autism and epilepsy. The ...

over the past decade epilepsy researchers have increasingly discussed and promoted the concept of targeting underlying brain mechanisms of epileptogenesis and injury that cause epilepsy and its ...

The Laboratory of Epilepsy and Emotional Behavior, led by Vaishnav Krishnan, M.D., Ph.D., is devoted to advancing our knowledge of the basic neurobiological mechanisms that underlie the strong ...

Nearly 500 people from the NGO participated in Tata Mumbai Marathon 2025 on January 19. Among them, 287 were individuals with ...

Lacosamide is a functionalized amino acid (with similarity to d-serine) that is approved by the US FDA and EMEA as an adjunctive therapy for partial-onset seizures. Lacosamide is believed to exert ...

typically focus on the disorder directly,” Smith said. “It often doesn’t branch out into disorders such as epilepsy where they often co-occur. Our study is unique because, by focusing on patients with ...